May 21, 2020 Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.…
Recent Post
- Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
- Safe Handling of Narcotic and Psychotropic Drugs in a Wholesale Warehouse: A Complete Guide
- Understanding the Requirements for a Validation Master Plan (VMP) as per Regulatory Agencies: USFDA, EU GMP, MHRA, and PIC/S
- Complete Procedure to Meet CDSCO License Mandate of Class C & D Non-Notified Medical Devices
- Complete list of approved FDC